BIOIDENT Wins Illustrious 2007 Wall Street Journal Technology Innovation Awards

Menlo Park, CA - BIOIDENT Technologies Inc., the leading company in the development of printed opto-electronic solutions for life sciences, recently announced that the company is a co-winner in the semiconductor category for the seventh annual Wall Street Journal contest for Technology Innovation. BIOIDENT was awarded for the development of its PhotonicLab Platform, which enables rapid in-vitro diagnostics, chemical and biological threat detection, and environmental testing without the need for off-site lab analysis.

"We are delighted to win this prestigious award that recognizes our innovative work on the cutting edge of nanotechnology," said Dr. Wasiq Bokhari, CEO for BIOIDENT. "Once again, BIOIDENT is being acknowledged as the pioneer in applying its unique printed opto-electronics to real-world applications. We will continue to leverage our unique technology to develop new solutions to address major industry challenges."

Utilizing the latest breakthroughs in science and nanotechnology, the BIOIDENT PhotonicLab Platform is used to produce the world's first disposable photonic lab-on-a-chip solution for next-generation mobile analytics applications, such as water and food analysis, chemical and biological agent detection, and point-of-care diagnostics. BIOIDENT employs a process developed by its parent company, Austria's NANOIDENT Technologies AG, for using an inkjet printer to print electronic circuits on a variety of surfaces, such as plastic foil or glass; the technology makes it possible to apply photosensitive semiconductors directly onto a lab-on-a-chip. The Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays.

SOURCE: BIOIDENT Technologies Inc.